News on Alpha Innotech from BioPortfolio.com http://www.BioPortfolio.com Consolidated Alpha Innotech news from BioPortfolio.com Wed, 10 Feb 2010 06:49:35 GMT en Kamada Announces Enrollment Of First Patient In Its Pivotal Study For Inhaled AAT In Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=0&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=0&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Life Sciences: Research in the area of life sciences reported from Monash University, Department of Physiologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039722&HITNO=1&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039722&THISHREF=http://c.moreover.com/click/here.pl%3fz2538341954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039722&HITNO=1&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039722&THISHREF=http://c.moreover.com/click/here.pl%3fz2538341954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Life Sciences: Study results from Ajinomoto Co., Inc. broaden understanding of life scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039750&HITNO=2&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039750&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039750&HITNO=2&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039750&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Alpha-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039803&HITNO=3&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039803&THISHREF=http://c.moreover.com/click/here.pl%3fz2538383480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039803&HITNO=3&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039803&THISHREF=http://c.moreover.com/click/here.pl%3fz2538383480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Novartis buys rights to Debiopharm's hep C drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039558&HITNO=4&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039558&THISHREF=http://c.moreover.com/click/here.pl%3fz2538215453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039558&HITNO=4&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039558&THISHREF=http://c.moreover.com/click/here.pl%3fz2538215453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Spinal Muscular Atrophy Therapy: Research from Ohio State University has provided new information about spinal muscular atrophy therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039729&HITNO=5&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039729&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039729&HITNO=5&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039729&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=6&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=6&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Stock Repurchase Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032740&HITNO=7&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032740&THISHREF=http://c.moreover.com/click/here.pl%3fz2534793108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032740&HITNO=7&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032740&THISHREF=http://c.moreover.com/click/here.pl%3fz2534793108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032207&HITNO=8&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032207&THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032207&HITNO=8&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032207&THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038570&HITNO=9&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038570&THISHREF=http://c.moreover.com/click/here.pl%3fz2537660103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038570&HITNO=9&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038570&THISHREF=http://c.moreover.com/click/here.pl%3fz2537660103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038487&HITNO=10&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038487&THISHREF=http://c.moreover.com/click/here.pl%3fz2537626834%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038487&HITNO=10&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038487&THISHREF=http://c.moreover.com/click/here.pl%3fz2537626834%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038482&HITNO=11&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038482&THISHREF=http://c.moreover.com/click/here.pl%3fz2537625316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038482&HITNO=11&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038482&THISHREF=http://c.moreover.com/click/here.pl%3fz2537625316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038424&HITNO=12&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038424&THISHREF=http://c.moreover.com/click/here.pl%3fz2537606747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038424&HITNO=12&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038424&THISHREF=http://c.moreover.com/click/here.pl%3fz2537606747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038287&HITNO=13&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038287&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038287&HITNO=13&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038287&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038286&HITNO=14&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038286&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038286&HITNO=14&MSIZE=818&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alpha%20Innotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038286&THISHREF=http://c.moreover.com/click/here.pl%3fz2537556358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: